Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Intermittent hypoxia-induced endothelial barrier dysfunction requires ROS-dependent MAP kinase activation.
Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.
Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust. Drugs. 2001; 61(2):197-206.
View in:
PubMed
subject areas
Anticholesteremic Agents
Clinical Trials as Topic
Contraindications
Coronary Disease
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Naphthalenes
Stroke
Violence
authors with profiles
Michael H. Davidson